Serological methods for the epidemiological study of Streptococcus pyogenes, such as T-, or M-typing, were replaced by emm typing in the 2000s. The frequency of emm types may differ according to geographical area and study period. Erythromycin resistance rates and the prevalence of erythromycin-resistant phenotypes in several countries are surveyed, and common emm genotypes associated with erythromycin resistance are described for each country. There is no correlation between erythromycin resistance and macrolide use in Korea. S. pyogenes is thought to cause severe illness, such as streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis. The mortality rate of STSS is about 50%, and there have been several hundred victims of STSS in Japan in the last 2 decades. The resistance rate to macrolides peaked at 50% in 2002, and currently, ＜10% of strains exhibit macrolide resistance in Korea. However, the erythromycin resistance rate recently exceeded 90% in China. Considering increases of travel between neighboring countries, a vigilant survey to monitor these highly virulent and antibiotic-resistant strains is necessary. (Korean J Clin Microbiol 2011;14:119-125)
INTRODUCTION
Streptococcus pyogenes, also known as group A streptococci (GAS), is a major pathogen that causes acute bacterial pharyngitis, often resulting in nonsuppurative sequelae, such as rheumatic fever (RF) and post-streptococcal glomerulonephritis (PSGN). While these secondary sequelae were a global threat in the early 20th century, improvement of personal hygiene, better nutrition and the invention of penicillin have made these sequelae rare in developed countries. However, these diseases are still major public health problems in the developing world. Moreover, several outbreaks of RF were reported in the USA during the 1980s [1] . Strains M1, M3, and M18 were more frequently isolated from patients with severe invasive infections as well as strains M3 and M18 from patients with RF than from normal controls [2] . The mucoid type, M3, was a major cause of the resurgence of RF [1] . The most striking diseases caused by GAS are necrotizing fasciitis and streptococcal toxic shock syndrome (STSS), or toxic shock-like syndrome, which was described in the early 1990s in the developed world. The mortality rate of STSS has reached 50%, which is 10 times higher than that of toxic shock syndrome caused by Staphylococcus aureus [3] . During the past few decades in Japan, there have been several hundreds of victims of STSS caused by group A, C, or G streptococci [4] . Although STSS cases are rarely reported in Korea, an increased awareness and understanding of this disease should be emphasized. A clinical trial testing a vaccine against the 26-valent serotype of GAS is currently underway [5] . GAS infects only human beings, making it difficult to determine the mechanisms of RF or PSGN, which are currently unknown.
Many virulence factors, such as streptococcal pyrogenic exotoxin A (SPE A), have been suggested as a cause of STSS; however, this linkage has not been established, and there are still unknown mechanisms to be discovered [3, 4] . Considering the high mortality rate of STSS and the proximity of Korea to Japan, outbreaks of this fatal illness should be closely monitored. The clinical course of STSS is so rapid that sometimes a diagnosis will be incomplete or missed altogether, which is a major problem because most cases of STSS require urgent surgical debridement as part of the treatment regimen [3] .
CARRIER STUDY
A carrier of GAS is defined as a person who has a throat culture positive for GAS but who does not have a sore throat or immunologic response [6] . Carriers may transfer GAS to close contacts, such as classmates or friends and family members. The carrier study is useful to enhance our understanding of the epidemiology of GAS and to conduct a survey of antibiotic resistance in the community. A study demonstrated an association between an increased carriage rate of an invasive streptococcal clone among school children and the outbreak of invasive streptococcal disease [7] . As GAS is common in elementary school children, most carrier studies have been performed using this group. Throat culture results can be completed in a short period of time, even for a large-scale study. Serotypes or the antibiotic resistance of GAS identified in carriers may overlap with those isolated from true infections in the same area. The carrier rate of GAS ranged from 8% to 18% among elementary school children in Korea [8] .
EPIDEMIOLOGICAL STUDY

Serotyping
There are several antigens on the cell wall surface of GAS.
The T, OF, and M antigens were commonly used for epidemiological purposes until the 1990s. The T typing test is based on slide agglutination with anti-T sera, which is commercially available. Although the T typing test is convenient to perform, it often causes cross-reactions that resulted in vague interpretations. Certain M proteins do not induce anti-M sera in the rabbit, and these were named opacity factors (OF) because they turned the horse serum opaque. Therefore, the OF antigen is equivalent to M protein such that OF4 is the same as M4. OF antibodies to M4, M2, M75, and M48 were the most common in the USA [9] , while antibodies to M4, M28, M22 were more common in Korean children [10] . Instead of rabbit anti-M sera, human sera were used for OF typing in a 96-well microplate opacity method [9] . The M protein is the most important virulence factor of GAS, as it inhibits GAS phagocytosis by neutro- 
ANTIBIOTIC RESISTANCE
Treatment regimens
Antibiotic treatment is necessary to reduce unwanted sequelae and to prevent the spreading of these bugs to the other people.
However, the use of antibiotics should be restricted to cases of bacterial pharyngitis, and should not be used for cases of viral pharyngitis. Overuse or misuse of antibiotics is a social concern and should be discouraged, as these practices may increase the selective pressure on the bugs resulting in an increase in anti- biotic resistance. Although penicillin is the drug of choice to eradicate GAS in the throat, oral penicillin V is no longer available in Korea. Moreover, Korean physicians are hesitant to use injectable penicillin due to the risk of shock allergy. Although other oral penicillins or cephalosporins are safe and easy to take, they are not very effective against intracellular organisms.
GAS is located in both extra-cellular and intra-cellular compartments. Macrolides are adequate alternative drugs that effectively kill intracellular organisms, and these can be used for patients who are allergic to penicillin. Macrolides are also effective against other etiological agents that cause respiratory tract infections, such as chlamydia and mycoplasma [15] . Long-acting macrolides, such as azithromycin or clarithromycin, have been increasinggly used to treat infections, and these are more likely to induce resistance than erythromycin.
Mechanism of macrolide resistance
The macrolides, lincosamides and streptogramin B, also called MLSB, have similar structures and antibacterial spectra. rRNA, whereas the M phenotype is caused by efflux. Resistance due to other mechanisms, e.g., 23S rRNA mutation, is rare.
Macrolide resistance rates and phenotype distribution
It is worthwhile to compare the trend of macrolide resistance and its phenotypic distribution by country ( Table 1 ). The emergence of erythromycin resistance (41.3%) was encountered in Seoul, Korea beginning in 1998 [16] . An even higher peak of erythromycin resistance (51%) was observed in Jinju, Korea in 2002 [17] ; however, this peak dropped sharply to 9.8% in the same area in just over 2 years [12] . The cMLSB phenotype was predominant in both of these two studies. The erythromycin resistance rate of GAS strains collected between 1980 and 1992 was 2% [18] . GAS strains isolated between 1990 and 2000 showed resistance rates of 16.1% and 9.8% to erythromycin and clindamycin, respectively in Wonju, Korea [19] . In that report, erythromycin resistance was first observed in 1994. Although the number of isolates tested was low (23 strains), phenotypic distribution showed 9, 6, and 8 strains each for the cMLSB, iMLSB, and M phenotypes, respectively [19] . Erythromycin resistance was observed in 23% of clinical isolates collected between 1997 and 2003 in Seoul [20] . Among the 51 erythromycin-resistant strains, the cMLSB phenotype accounted for 31%, the iMLSB phenotype for 51%; and the M phenotype for 18% [20] . Another large-scale study in Korea showed that the M (45%) and cMLSB (42%) phenotypes were rather common among 126 erythromycin-resistant strains in 1998-2003 [13] .
The overall rate of erythromycin resistance was 25 [23] . In this study, they collected pharyngeal isolates from different locations and at different times, and as a result, they observed variable rates by site (3.0-8.7%) and by month (＜2% to ＞10%). Over 60% of the macrolide-resistant isolates presented with the M phenotype in this study [23] .
Another study in the USA during the same time period showed that resistance rates to erythromycin and clindamycin were 6.8% and 0.5%, respectively, among 1,885 isolates [24] . The macrolide-resistance phenotype distribution of strains in this study was as follows: cMLSB was 9%, iMLSB was 47%, and the M phenotype was present in 44% of resistant strains. Among the 129 erythromycin-resistant strains, three predominant emm types were observed: emm75, emm12, and emm58 [24] . In a long-term study conducted in Spain from 1993 to 2008 [25] , the erythromycin resistance trend coincidently overlapped with ours.
Erythromycin resistance rates progressively increased from 0% to erythromycin and clindamycin were 14.9% and 1.4%, respectively, in Greece [28] , suggesting that most of these isolates were of the M phenotype.
Antimicrobial consumption and antimicrobial resistance
It is well known that erythromycin resistance of GAS in Japan used to be very high (over 60%) in the 1970s, with a substantial decrease in erythromycin resistance since the 1980s [29, 30] . The reduction of macrolide usage is postulated as a major reason for the decrease in erythromycin resistance in Japan.
Scientists in Finland demonstrated a close association between erythromycin resistance of GAS and the consumption of this drug [31] . The incomparably high resistance rate (＞95%) to macrolides in China in the late 2000s is a worrisome trend [21] , as well, particularly because most of these strains had the cMLSB phenotype. As these highly resistant strains are interchangeable between neighboring countries, a vigilant survey should be conducted to monitor these strains.
The resistance rate of erythromycin, class drug of the macrolides, showed a peak (51%) in 2002, which dropped dramatically to 10% in 2004 in Jinju [12] , and is currently less than 10%. However, the author has found that the consumption of macrolides, especially new macrolides, such as azithromycin, roxythromycin, and clarithromycin, has recently increased [32] .
The author has suggested that the change of distribution of emm genotypes may affect the resistance rate more so than reducing the use of antibiotics in Korea [32] . A Spanish group observed a similar phenomenon: the frequency of erythromycin-resistant GAS was altered by the emergence of epidemic clones susceptible to erythromycin [33] , and these arose without changes in the use of macrolides.
emm genotype and antimicrobial resistance
There is a discrepancy in the association between emm genotype and erythromycin resistance reported by country ( Table 2 ).
The author reported strong associations between emm12 and cMLSB, and emm18 and emm75 with M phenotype in 2002 [17] . While all iMLSB strains harbored the emm12 genotype, nine of 16 cMLSB had the emm28 type observed in Seoul [20] .
There was a strong positive association between emm12 and the erm(B) gene in Korea, where 87.7% of the emm12 genotype contained the erm(B) gene [13] . The emm12 genotype seemed to be the most resistant genotype in Korea [13, 17, 32] . The emm75 genotype seemed to be associated with M phenotype [17, [23] [24] [25] . The most common emm genotypes representing erythromycin resistance were emm22 (85.7%) in Hong Kong [21] , emm1
(86.2%) and emm12 (91.8%) in China [22] , and emm77 (17.9%) and emm4 (16.8%) in Greece [28] . Almost all strains harboring the emm22 gene had the cMLSB phenotype, and more than 80%
of the emm89 and emm4 positive strains presented with the iMLSB and M phenotypes, respectively, in Italy [27] . Among the M phenotype isolates, the most frequent genotypes (88.5%)
were emm4, emm6, and emm75, while emm11, emm28, and emm25 accounted for 72.5% of MLSB phenotype isolates in Spain over a period from 1993-2008 [25] . Another study supported the relationship between emm types and the MLSB phenotype reported in Spain. In that study, the most prevalent genotypes were emm11 and emm28 in isolates collected from 1999 to 2005, and these had the MLSB phenotype [26] . In the other study in Spain, emm4, ST1815, and emm75 had been predominantly observed in erythromycin-resistant strains from 1996-1999 [34] ; however, the emm12 genotype was common both in erythromycin-resistant and susceptible strains. The finding of diverse emm types representing erythromycin resistance that varies by country indicates that the M protein does not play a role in the passage of resistance gene clusters (e.g., transposon) through the cell wall. Clonal expansion of resistant strains in a given region is more likely the cause, rather than susceptibility of certain M proteins to resistance genes. However, more studies should be conducted to elucidate the mechanism of macrolide resistance. That no penicillin-resistant GAS strains have been identified, worldwide [35] , despite the fact that a very high resistance rate to penicillin occurs in Streptococcus pneumoniae, has yet to be fully elucidated. 
